Decreased Rates for Cervical Cancer Screening Should Lead to Strategic Shifts for Clinical Labs
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Cybersecurity expert explains the importance of such assessments, which simulate malicious attacks to identify IT vulnerabilities.
How clinical laboratories can get started in automation—and what to consider when doing so.
Laboratory leader Ihab Abumuhor discusses recent lab automation-related developments and the keys to successful implementation.
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.